(Inhibition, regulation, isoenzymes & specificity) DrArun Kumar K Inhibition

Enzyme activity is decreased by certain compounds known as inhibitors. The process is called enzyme inhibition. 1. 2.Non competitive inhibition 3.Uncompetitive inhibition 4.Suicide inhibition 5.Allosteric inhibition 1. Competitive inhibition

• Competition b/w substrate and inhibitor for substrate binding site. • Inhibitor is a structural analogue of substrate. • E+I EI ; No product • Reversible. Can be reversed by increasing substrate conc. • Increased Km, No change in V max. • Example : Succinate dehydrogenase inhibited by Malonate

Examples for Clinical Applications of Competitive Inhibition (drugs) • 1)Allopurinol – Xanthine Oxidase (Gout). • 2) Dicumarol – Vitamin K Epoxide reductase (Anticoagulant) • 3) Sulfonamide- Pteroid synthase (Antibiotic) • 4) & Aminopterin- (Anticancer drug) • 5) Neostigmine –Acetyl cholinesterase (Myasthenia Gravis) • 6) Lovastatin – HMG CoA Reductase, (Hypercholesterolemia) • 7) Succinyl choline: Acetyl choline esterase (muscle relaxation in surgery) • 8) Ephidrene, Amphetamine: Mono Amino Oxidase (Hypotension) • 9) Ethanol in methanol poisoning: Alcohol Dehydrogenase. Noncompetitive Inhibition

• There is no competition. • Inhibitor is not a structural analogue. • binds to site other than active site. • Generally Irreversible. Can not be reversed by increasing substrate concentration.

• V Max decreased ; Km unchanged.

Examles for noncompetitive inhibition (poisons)

Cyanide – Cytochrome oxidase Diisopropyl fluorophosphate (DIFP) - . Fluoride- Enolase Iodoacetate : -SH enzymes (Glyceraldehdye 3- phosphate Dehydrogenase). 3. Uncompetitive Inhibition

• Inhibitor Binds only to ES (not to free enzyme). • Both Km and V Max decreased. • Example : Inhibition of placental alkaline phosphatase by Phenylalanine. Suicide Inhibition (Mechanism based inactivation) • Structural analog of the substrate is converted to a more effective inhibitor by the action of the enzyme to be inhibited. • This new inhibitor formed irreversibly binds to the enzyme and inhibits it. • Irreversible inhibition. • Examples: • 1) Allopurinol (→Alloxanthine) – Xanthine oxidase Hypoxanthine ---→ xanthine • 2) (anti inflammatory agent) - . Arachidonic acid ----→ prostaglandins. • 3) Di Fluoro Methyl Ornithine (DFMO- treatment of trypanosomiasis) – Ornithine -----→ Putrescine 5. Allosteric inhibition

• Type of enzyme regulation. Enzyme regulation

• Activity of certain can be increased or decreased depending on the need of the cell. • These enzymes are called Regulatory enzymes. • Types: • 1. Allosteric regulation • 2. Covalent modification • 3. Induction • 4. Repression. Allosteric Regulation (Allos = other)

SUBSTRATE BINDING SITE ALLOSTERIC SITE

ALLOSTERIC ENZYME 1. Allosteric Regulation (Allos = other) • Allosteric enzyme has a site other than catalytic site known as allosteric site. • It is for modifiers to bind. • The binding of the regulatory molecule can either • enhance the activity of the enzyme – allosteric activation, or • inhibit the activity of the enzyme - allosteric inhibition. Allosteric activation

• The binding of the regulatory molecule to allosteric site enhances activity of the enzyme. • The modifier is called- positive modifier. ALLOSTERIC ENZYME ALLOSTERIC ACTIVATOR Phosphofructokinase AMP & Fructose 2,6 Bis hosphate Aspartate transcarbamoylase ATP

Pyruvate carboxylase Acetyl CoA

Acetyl CoA-carboxylase Citrate

Carbamoyl phosphate N- Acetyl Glutamate synthetase I Allosteric inhibition

• The binding of regulatory molecule to allosteric site decreases activity of the enzyme. • The modifier is negative modifier. • When an inhibitor binds to allosteric site, • configuration of catalytic site is modified • such that substrate cannot bind properly. • The inhibitor is not a substrate analog. • It is partially reversible, when excess substrate is added. • Km is usually increased, Vmax is reduced ALLOSTERIC ENZYME ALLOSTERIC INHIBITOR Phosphofructokinase ATP & Citrate Aspartate transcarbamoylase CTP

Pyruvate carboxylase ADP

Acetyl CoA-carboxylase Acyl CoA

Carbamoyl phosphate UTP synthetase II feedback inhibition or end-product inhibition – activity of the enzyme is inhibited by the final product of the biosynthetic pathway. 2. Covalent modification

• It is a type of enzyme regulation. • There is either addition of a group to the enzyme by forming a covalent bond; or • removal of a group by cleaving a covalent bond. • Types: i. Irreversible ii. Reversible i. Irreversible covalent modification

• Activation of enzyme by breaking a covalent bond present the enzyme. • Once activated cannot be converted back to original inactive form. • Examples • Zymogen activation by partial proteolysis. Partial Proteolysis PROENZYME ACTIVE ENZYME + POLYPEPTIDE Peptide bond PROENZYMES / ACTIVE ENZYMES ZYMOGENS 1 PEPSINOGEN PEPSIN

2 TRYPSINOGEN TRYPSIN

3 CHYMOTRYPSINOGEN CHYMOTRYPSIN

4 PROELASTASE ELASTASE ii. Reversible covalent modification

• By Addition or removal of a group such as i. phosphate group (phosphorylation– dephosphorylation) – (most common). ii. ADP-ribose group (rare) Pi ATP PROTEIN PHOSPHATASE PROTEIN KINASE Dephosphorylation Phosphorylation ADP H20 Enzyme Phosphorylated form Acetyl-CoA Inactive carboxylase Glycogen synthase Inactive

Pyruvate Inactive dehydrogenase HMG CoA Inactive reductase Pyruvate kinase Inactive

Phosphorylated form is Inactive Enzyme Phosphorylated form

Glycogen Active phosphorylase Phosphorylase b Active kinase HMG CoA Active reductase kinase

Phosphorylated form is Active 3. Induction

• Process of increasing rate of synthesis of enzyme in the presence of inducer. • Induction is effected through the process of derepression. • The inducer will relieve the repression on the operator site and • will remove the block on the biosynthesis of the enzyme molecules. Inducible inducer enzyme 1 Tryptophan glucocorticoids pyrrolase 2 transaminase glucocorticoids 3 Glucokinase insulin 4 ALA barbiturates synthase 4. Repression

• Process of decreasing rate of synthesis of enzyme in the presence of repressor. • Examples: • ALA synthase is repressed by heme. • HMG CoA reductase is repressed by Cholesterol. • Inhibition by the end product of the pathway is called FEEDBACK Inhibition Isoenzymes

• Multiple (physically distinct) forms of the same enzyme which catalyze the same reaction but differ in • Physical • Chemical • Immunoloical properties and • Electrophoretic mobilities. Types of isoenzymes

1. Product of different genes (true isoenzymes) 2. Which differ in subunit composition. 3. Which differ in prosthetic group composition (iso-forms). 1. Product of different genes Example: Salivary amylase and Pancreatic amylase 2. Which differ in subunit composition Example: i. Creatine kinase ii. Lactate Dehydrogenase(LDH). 3. Isoenzymes which differ in prosthetic group composition. • Example: • Alkaline Phosphatase (ALP) • ALP hydrolyzes compounds containing phosphate under alkaline condition (optimum pH is between 9 and 10). • Zinc is a constituent ion of ALP • Contains sialic acid as prosthetic group. Separation of isoenzymes

1. Agar gel or polyacrylamide gel electrophoresis. 2. Difference in Heat stability. 3. Using Inhibitors. 4. Difference in affinity for substrate 5. Using Specific antibodies Enzyme specificity

• Enzymes are specific in their action. • 4 types: 1. Absolute specificity 2. Group specificity 3. Bond specificity 4. Stereospecificity 1. Absolute specificity

• Enzymes which show absolute specificity are specific about - (a) their substrate and - (b) type of reaction. Example: 1. Urease catalyzes hydrolysis of Urea. 2. Glucose oxidase catalyzes oxidation of glucose. 2. Group specificity

• These enzymes are specific about a particular group present in their substrate. • Example: 1. Hexokinase can add phosphate to - glucose, - galactose and - mannose. 3. Bond specificity

• Are specific about a particular bond present in their substrate. • Example: 1. Trypsin hydrolyzes peptide bonds of any protein - hydrolyzes internal peptide bonds involving carboxyl groups of arginine or lysine residues. 2. Chymotrypsin – internal peptide bond - Phe and Tyr 4. Stereospecificity

• These enzymes are specific about stereo isomeric form of their substrate. • Example: 1. Hexokinase acts only on D- Glucose 2. Transaminases act only on L- Amino acids. The activity of an enzyme is also sensitive to the presence of specific chemicals that bind to the enzyme. When the binding of the chemical shuts off enzyme activity, the process is called ______and the chemical is called an ______. (a) activation, activator (b) inhibition, inhibitor (c) Inhibition, promoter (d) activation, inhibitor Inhibition of succinate dehydrogenase by malonate is an example of (a) Non-competitive inhibition (b) Negative feed back (c) Allosteric inhibition (d) Competitive inhibition Which one of the following statement is incorrect? (a) A competitive inhibitor reacts reversibly with the enzyme to form an complex (b) In competitive inhibition, the inhibitor molecule is not chemically change by the enzyme (c) The competitive inhibitor does not affect the rate of breakdown of the enzyme subtract complex (d) The present of the competitive inhibitor decreases the Km of the enzyme for the substrate. Suicidal Enzyme is: a. Lipoxygenase b. Cyclooxygenase c. Thromboxane Synthase d. 5’ Nucleotidase Noncompetitive enzyme inhibition leads to: a. Vmax ↑ b. Vmax ↓ c. Vmax unchanged d. Km ↑ e. Km ↓ True about competitive inhibition of enzyme: a. ↑ Km b. ↓ Km c. ↑ Vmax d. No change in Km and Vmax e. Vmax remain same Noncompetitive reversible inhibitors: a. Raise Km b. Lower Km c. Lower Vmax d. Raise both Vmax and Km. e. Do not affect either Vmax or Km Km changes and Vmax remains the same. What is the type of Enzyme inhibition? a. Competitive Inhibition b. Noncompetitive Inhibition c. Uncompetitive inhibition d. Suicide Inhibition Chymotrypsinogen is a: a. Zymogen b. Carboxypeptidase c. Transaminase d. Exopeptidase Trypsin is a: a. Serine protease b. Lecithinase c. Phospholipase d. Elastase